RHYTHM PHARMACEUTICALS, INC. (RYTM) has 14 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 5 sales totalling $26.5M. Most recent filing: Sept. 14, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 14, 2026 | Meeker David P President and CEO | $4,830,942 | 150,000 | 0% | Yes | |
|
|
||||||
| Sept. 1, 2026 filed Aug. 31, 2026 | Smith Hunter C Chief Financial Officer | −$589,184 | 177,148 | −59% | Yes | |
|
|
||||||
| Aug. 18, 2026 filed Aug. 17, 2026 | Joshi Manher Chief Medical Officer | $0 | 75,000 | 0% | No | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 13, 2026 | Shulman Joseph Chief Technical Officer | −$365,836 | 9,127 | −34% | Yes | |
|
|
||||||
| Aug. 17, 2026 filed Aug. 13, 2026 | Garfield Alastair Chief Scientific Officer | −$912,703 | 7,763 | −77% | Yes | |
|
|
||||||
Showing the 5 most recent of 14 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free